IIA
VRTX icon

ICW Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

ICW Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Buy
765
+101
+15% +$47.1K 0.12% 132
2025
Q4 		$301K Buy
664
+32
+5% +$13.8K 0.11% 133
2025
Q3 		$247K Buy
632
+28
+5% +$11.7K 0.09% 140
2025
Q2 		$269K Buy
604
+29
+5% +$13.4K 0.11% 135
2025
Q1 		$279K Buy
575
+18
+3% +$8.39K 0.11% 134
2024
Q4 		$224K Buy
557
+3
+0.5% +$1.39K 0.09% 138
2024
Q3 		$258K Buy
+554
New +$266K 0.11% 136

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ICW Investment Advisors's VRTX Position: Q1 2026 in Review

ICW Investment Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 15% in Q1 2026, buying an estimated $47.1K and bringing the position to 765 shares worth $342K. The position accounts for 0.12% of the portfolio, ranked #132.

ICW Investment Advisors first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • ICW Investment Advisors held 765 shares of Vertex Pharmaceuticals worth $342K as of Q1 2026.
  • ICW Investment Advisors bought 101 Vertex Pharmaceuticals shares in Q1 2026, an estimated $47.1K.
  • Vertex Pharmaceuticals made up 0.12% of ICW Investment Advisors's portfolio in Q1 2026, its #132 holding.
  • ICW Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.